> It is not a matter of the shipping cost.
Seems like your original point was centered on shipping costs destroying domestic businesses. In light of the downvotes it became mostly a matter of drug imports in small, cheap packages:
> most fentayl imports are less than 700 grams - which get lost in the massive flood of UPS e-Packet shipments and thus near impossible to inspect
Which is irrelevant, shipping costs (within reason) won't change this.
I made both points right at the beginning, though the thread got focused around one of them.
1. e-packet shipping cost adversely affecting US businesses
2. e-packet being used to hide fentayl shipments thanks to massive volume and delivery convenience. (cheap and fast)
"Which is irrelevant, this will be the case regardless of the shipping costs, within reason."
I fail to understand this statement. How will reduction of e-packets - one of the major causes of the bloat of international packages not help in inspection ?
If you reduce the total number of e-packets by removing the subsidy, then it becomes far easier to inspect which packages have fentayl and which do not. EMS shipments apparently quadrupled after the e-packet scheme was introduced which adversely affected all inspection procedures as agencies could not cope with the volume.
Reduce the volume by removing the subsidy - the inspection agencies can then manage their job.
1. Chinese fentayl shipments do not need to have high weight due to purity. Mentioned explicitly in the trade commission report linked above.
2. Due to 1), it is convenient to leverage e-packet shipment as inspection of massive volume of e-packet shipments is near impossible.
3. Small-scale US businesses were adversely affected by e-packet rates https://www.theatlantic.com/technology/archive/2018/10/trump...